134 related articles for article (PubMed ID: 2516402)
21. Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.
Murphy SB; Cohn SL; Craft AW; Woods WG; Sawada T; Castleberry RP; Levy HL; Prorok PC; Hammond GD
Lancet; 1991 Feb; 337(8737):344-6. PubMed ID: 1671243
[No Abstract] [Full Text] [Related]
22. Biochemical screening for neuroblastoma in infants: a feasibility study.
Craft AW; Dale G; McGill A; Seviour J; Spence EM
Med Pediatr Oncol; 1989; 17(5):373-8. PubMed ID: 2796853
[TBL] [Abstract][Full Text] [Related]
23. More on gas-liquid chromatographic determination of homovanillic and vanillylmandelic acids in urine from cases of neuroblastoma.
Melchert HU; Hoffmeister H
Clin Chem; 1978 May; 24(5):842-3. PubMed ID: 647929
[No Abstract] [Full Text] [Related]
24. Fluctuation in the concentrations of vanillylmandelic acid and homovanillic acid in mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Yamashiro K; Takasugi N; Hanai J; Kawai T
Eur J Pediatr; 1990 Sep; 149(12):859-61. PubMed ID: 2226572
[TBL] [Abstract][Full Text] [Related]
25. Feasibility study for neonatal neuroblastoma screening in the United States.
Tuchman M; Fisher EJ; Heisel MA; Woods WG
Med Pediatr Oncol; 1989; 17(4):258-64. PubMed ID: 2747596
[TBL] [Abstract][Full Text] [Related]
26. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1987 Sep; 17(3):221-8. PubMed ID: 3669365
[TBL] [Abstract][Full Text] [Related]
27. [Mass screening for early detection of neuroblastoma].
Gershoni-Baruch R; Benderly A
Harefuah; 1989 Oct; 117(7-8):218-9. PubMed ID: 2684819
[No Abstract] [Full Text] [Related]
28. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
Tuchman M; Lemieux B; Auray-Blais C; Robison LL; Giguere R; McCann MT; Woods WG
Pediatrics; 1990 Nov; 86(5):765-73. PubMed ID: 2152340
[TBL] [Abstract][Full Text] [Related]
29. Simple method for the determination of homovanillic acid and vanillylmandelic acid in urine by high-performance liquid chromatography.
Yoshida A; Yoshioka M; Sakia T; Tamura Z
J Chromatogr; 1982 Jan; 227(1):162-7. PubMed ID: 7056807
[No Abstract] [Full Text] [Related]
30. [Vanillylmandelic acid (VMA) and homovanillic acid (HVA)].
Kanesaka Y; Tomita K
Nihon Rinsho; 1999 Dec; 57 Suppl():223-5. PubMed ID: 10778106
[No Abstract] [Full Text] [Related]
31. Mass screening for neuroblastoma in infants.
Wei M; Ye M; Dong K; Dong R
Discov Med; 2020; 30(160):63-70. PubMed ID: 33382962
[TBL] [Abstract][Full Text] [Related]
32. [Rapid determination of 4-hydroxy-3-methoxymandelic (vanilmandelic) acid and 4-hydroxy-3-methoxyphenylacetic (homovanillic) acid in urine by liquid chromatography with electrochemical detection].
Satokata I; Asami T; Otsuka T; Sakai K
Rinsho Byori; 1986 Jul; 34(7):817-22. PubMed ID: 3761638
[No Abstract] [Full Text] [Related]
33. Mass screening for neuroblastoma in Japan.
Sawada T; Sugimoto T; Kawakatsu H; Matsumura T; Matsuda Y
Pediatr Hematol Oncol; 1991; 8(2):93-109. PubMed ID: 1863547
[TBL] [Abstract][Full Text] [Related]
34. Interchangeability between 24-hour collection and single spot urines for vanillylmandelic and homovanillic acid levels in the diagnosis of neuroblastoma.
Cangemi G; Barco S; Reggiardo G; Viscardi E; Di Cataldo A; Garaventa A; Melioli G; Conte M
Pediatr Blood Cancer; 2013 Dec; 60(12):E170-2. PubMed ID: 23813598
[TBL] [Abstract][Full Text] [Related]
35. Excretion of octopamine metabolites in neuroblastoma.
Couch MW; Greer DM; Williams CM
Clin Chim Acta; 1986 Jul; 158(1):109-14. PubMed ID: 3091293
[TBL] [Abstract][Full Text] [Related]
36. Direct determination of urinary vanillylmandelic acid and homovanillic acid by high-performance liquid chromatography on an anion-exchange column.
Kodama K; Nakata T; Aoyama M
J Chromatogr; 1984 Nov; 311(2):369-74. PubMed ID: 6520184
[No Abstract] [Full Text] [Related]
37. Screening for neuroblastoma: a review of the evidence.
Chamberlain J
J Med Screen; 1994 Jul; 1(3):169-75. PubMed ID: 8790511
[TBL] [Abstract][Full Text] [Related]
38. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine.
Nishi M; Miyake H; Takeda T; Takasugi N; Sato Y; Hanai J
Jpn J Clin Oncol; 1987 Jun; 17(2):151-5. PubMed ID: 3613139
[TBL] [Abstract][Full Text] [Related]
39. Stability of urinary HVA and VMA on filter paper.
Cyr D; Giguère R; Tuchman M; Lemieux B
Early Hum Dev; 1997 Sep; 49(2):149-52. PubMed ID: 9226122
[TBL] [Abstract][Full Text] [Related]
40. Measurement of urinary vanillylmandelic acid (VMA) and homovanillic acid (HVA) for diagnosis of neural crest tumors.
Sawada T
Pediatr Hematol Oncol; 1997; 14(4):291-3. PubMed ID: 9211532
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
